Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s10549-008-9926-3.

Title:
Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA | Breast Cancer Research and Treatment
Description:
Background Breast cancers with a triple negative tumor (TNT) subtype (as defined by lacking protein expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2)) preclude the use of available targeted therapies and may contribute to poor outcome and to the historically poorest survival observed among African–American (AA) women. This study examines association of the ER/PR/HER2 subtypes with race and breast cancer survival. Methods Breast tumors from a population-based cohort of 116 AA and 360 white Atlanta women aged 20–54, diagnosed from 1990 to 1992 were centrally reviewed and tested by immunohistochemistry. Multivariate survival analyses within subtypes (TNT, ERāˆ’PRāˆ’HER2+, ER+/PR+HER2+, ER+/PR+HER2āˆ’) were conducted using weighted Cox regression and included socio-demographic, prognostic, and treatment factors. Results TNTs were more prevalent among young women and particularly among AA women (Odds Ratio [OR] = 1.9, 95% Confidence Interval [CI] 1.2–2.9), adjusting for age, stage, grade, and poverty index. Overall mortality was higher for AA women (Hazard Ratio [HR] = 1.9, 95% CI, 1.5–2.5) and differed by subtypes (P < 0.001). Within the TNT subtype, racial differences in survival persisted, after additional adjustment for treatment and comorbidities (HR = 2.0, 95% CI 1.0–3.7). TNTs were uniquely associated with high expression of p16, p53, and Cyclin E; and low Bcl-2 and Cyclin D1 expression. Conclusions The high prevalence of TNTs among younger women and particularly younger AA women, along with unique protein expression patterns and poorer survival, suggests varying gene–environment etiologies with respect to age and race/ethnicity and a need for effective therapies.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {šŸ“š}

  • Education
  • Health & Fitness
  • Science

Content Management System {šŸ“}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {šŸ“ˆ}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {šŸ’ø}

We see no obvious way the site makes money.

Some websites aren't about earning revenue; they're built to connect communities or raise awareness. There are numerous motivations behind creating websites. This might be one of them. Link.springer.com might be earning cash quietly, but we haven't detected the monetization method.

Keywords {šŸ”}

cancer, breast, google, scholar, article, pubmed, cas, expression, survival, women, receptor, study, subtypes, usa, atlanta, clin, carcinoma, protein, human, differences, res, pathol, gene, research, treatment, negative, lund, prognostic, clinical, natl, oncol, immunohistochemical, race, populationbased, cyclin, patients, molecular, analysis, triple, mary, estrogen, africanamerican, prevention, privacy, cookies, content, data, epidemiology, porter, otis,

Topics {āœ’ļø}

high/p27 low/p53+/glomeruloid-microvascular-proliferation+ month download article/chapter brca1-related breast cancer triple-negative breast cancer avidin-biotin-peroxidase complex drug administration-approved scoring called triple-negative phenotype el-rehim da triple negative tumor cell-cycle regulators p27kip1 newly diagnosed african–american er/pr/her2 subtypes single-institution compilation compared adjuvant anthracycline-treated patients breast tumor subtypes relapse-free survival mary jo lund full article pdf triple negative threats formalin- paraffin sections distinct disease entities luminal breast cancers breast cancer heterogeneity related subjects national cancer institute national cancer institute privacy choices/manage cookies gene expression analyses breast cancer subtypes multivariate survival analyses invasive breast carcinoma tumour growth fraction routinely processed tissues breast cancer survival gene expression profiling oak ridge institute young african american paraffin-embedded tissue tcf4-independent manner biochemically receptor negative breast cancer classification cdkn2/mts1 gene gene expression profiles breast carcinoma characteristics article lund population-based study erāˆ’prāˆ’her2+ er+/pr+her2+ er+/pr+her2āˆ’ oestrogen receptor negative

Questions {ā“}

  • Anderson WF, Matsuno R (2006) Breast cancer heterogeneity: a mixture of at least two main types?
  • Birnbaum D, Bertucci F, Ginestier C etĀ al (2004) Basal and luminal breast cancers: basic or luminous?
  • Fregene A, Newman LA (2005) Breast cancer in sub-Saharan Africa: how does it relate to breast cancer in African–American women?

Schema {šŸ—ŗļø}

WebPage:
      mainEntity:
         headline:Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA
         description:Background Breast cancers with a triple negative tumor (TNT) subtype (as defined by lacking protein expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2)) preclude the use of available targeted therapies and may contribute to poor outcome and to the historically poorest survival observed among African–American (AA) women. This study examines association of the ER/PR/HER2 subtypes with race and breast cancer survival. Methods Breast tumors from a population-based cohort of 116 AA and 360 white Atlanta women aged 20–54, diagnosed from 1990 to 1992 were centrally reviewed and tested by immunohistochemistry. Multivariate survival analyses within subtypes (TNT, ERāˆ’PRāˆ’HER2+, ER+/PR+HER2+, ER+/PR+HER2āˆ’) were conducted using weighted Cox regression and included socio-demographic, prognostic, and treatment factors. Results TNTs were more prevalent among young women and particularly among AA women (Odds Ratio [OR]Ā =Ā 1.9, 95% Confidence Interval [CI] 1.2–2.9), adjusting for age, stage, grade, and poverty index. Overall mortality was higher for AA women (Hazard Ratio [HR]Ā =Ā 1.9, 95% CI, 1.5–2.5) and differed by subtypes (PĀ <Ā 0.001). Within the TNT subtype, racial differences in survival persisted, after additional adjustment for treatment and comorbidities (HRĀ =Ā 2.0, 95% CI 1.0–3.7). TNTs were uniquely associated with high expression of p16, p53, and Cyclin E; and low Bcl-2 and Cyclin D1 expression. Conclusions The high prevalence of TNTs among younger women and particularly younger AA women, along with unique protein expression patterns and poorer survival, suggests varying gene–environment etiologies with respect to age and race/ethnicity and a need for effective therapies.
         datePublished:2008-03-07T00:00:00Z
         dateModified:2008-03-07T00:00:00Z
         pageStart:357
         pageEnd:370
         sameAs:https://doi.org/10.1007/s10549-008-9926-3
         keywords:
            African–American
            Breast cancer
            Race
            Survival
            Triple negative
            Tumor subtypes
            Oncology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-008-9926-3/MediaObjects/10549_2008_9926_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-008-9926-3/MediaObjects/10549_2008_9926_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-008-9926-3/MediaObjects/10549_2008_9926_Fig3_HTML.gif
         isPartOf:
            name:Breast Cancer Research and Treatment
            issn:
               1573-7217
               0167-6806
            volumeNumber:113
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Mary Jo Lund
               affiliation:
                     name:Emory University
                     address:
                        name:Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, USA
                        type:PostalAddress
                     type:Organization
                     name:Emory University School of Medicine
                     address:
                        name:Hematology and Oncology, Emory University School of Medicine, Atlanta, USA
                        type:PostalAddress
                     type:Organization
                     name:Emory University School of Medicine
                     address:
                        name:Winship Cancer Institute, Emory University School of Medicine, Atlanta, USA
                        type:PostalAddress
                     type:Organization
                     name:Emory University
                     address:
                        name:Georgia Cancer Center for Excellence at Grady, Emory University, Atlanta, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Katrina F. Trivers
               affiliation:
                     name:Centers for Disease Control and Prevention
                     address:
                        name:Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Peggy L. Porter
               affiliation:
                     name:Fred Hutchinson Cancer Research Center
                     address:
                        name:Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ralph J. Coates
               affiliation:
                     name:Centers for Disease Control and Prevention
                     address:
                        name:Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Brian Leyland-Jones
               affiliation:
                     name:Emory University School of Medicine
                     address:
                        name:Hematology and Oncology, Emory University School of Medicine, Atlanta, USA
                        type:PostalAddress
                     type:Organization
                     name:Emory University School of Medicine
                     address:
                        name:Winship Cancer Institute, Emory University School of Medicine, Atlanta, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Otis W. Brawley
               affiliation:
                     name:Emory University
                     address:
                        name:Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, USA
                        type:PostalAddress
                     type:Organization
                     name:Emory University School of Medicine
                     address:
                        name:Hematology and Oncology, Emory University School of Medicine, Atlanta, USA
                        type:PostalAddress
                     type:Organization
                     name:Emory University School of Medicine
                     address:
                        name:Winship Cancer Institute, Emory University School of Medicine, Atlanta, USA
                        type:PostalAddress
                     type:Organization
                     name:Emory University
                     address:
                        name:Georgia Cancer Center for Excellence at Grady, Emory University, Atlanta, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Elaine W. Flagg
               affiliation:
                     name:Centers for Disease Control and Prevention
                     address:
                        name:Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ruth M. O’Regan
               affiliation:
                     name:Emory University School of Medicine
                     address:
                        name:Hematology and Oncology, Emory University School of Medicine, Atlanta, USA
                        type:PostalAddress
                     type:Organization
                     name:Emory University School of Medicine
                     address:
                        name:Winship Cancer Institute, Emory University School of Medicine, Atlanta, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Sheryl G. A. Gabram
               affiliation:
                     name:Emory University School of Medicine
                     address:
                        name:Winship Cancer Institute, Emory University School of Medicine, Atlanta, USA
                        type:PostalAddress
                     type:Organization
                     name:Emory University
                     address:
                        name:Georgia Cancer Center for Excellence at Grady, Emory University, Atlanta, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:J. William Eley
               affiliation:
                     name:Emory University School of Medicine
                     address:
                        name:Hematology and Oncology, Emory University School of Medicine, Atlanta, USA
                        type:PostalAddress
                     type:Organization
                     name:Emory University School of Medicine
                     address:
                        name:Winship Cancer Institute, Emory University School of Medicine, Atlanta, USA
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA
      description:Background Breast cancers with a triple negative tumor (TNT) subtype (as defined by lacking protein expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2)) preclude the use of available targeted therapies and may contribute to poor outcome and to the historically poorest survival observed among African–American (AA) women. This study examines association of the ER/PR/HER2 subtypes with race and breast cancer survival. Methods Breast tumors from a population-based cohort of 116 AA and 360 white Atlanta women aged 20–54, diagnosed from 1990 to 1992 were centrally reviewed and tested by immunohistochemistry. Multivariate survival analyses within subtypes (TNT, ERāˆ’PRāˆ’HER2+, ER+/PR+HER2+, ER+/PR+HER2āˆ’) were conducted using weighted Cox regression and included socio-demographic, prognostic, and treatment factors. Results TNTs were more prevalent among young women and particularly among AA women (Odds Ratio [OR]Ā =Ā 1.9, 95% Confidence Interval [CI] 1.2–2.9), adjusting for age, stage, grade, and poverty index. Overall mortality was higher for AA women (Hazard Ratio [HR]Ā =Ā 1.9, 95% CI, 1.5–2.5) and differed by subtypes (PĀ <Ā 0.001). Within the TNT subtype, racial differences in survival persisted, after additional adjustment for treatment and comorbidities (HRĀ =Ā 2.0, 95% CI 1.0–3.7). TNTs were uniquely associated with high expression of p16, p53, and Cyclin E; and low Bcl-2 and Cyclin D1 expression. Conclusions The high prevalence of TNTs among younger women and particularly younger AA women, along with unique protein expression patterns and poorer survival, suggests varying gene–environment etiologies with respect to age and race/ethnicity and a need for effective therapies.
      datePublished:2008-03-07T00:00:00Z
      dateModified:2008-03-07T00:00:00Z
      pageStart:357
      pageEnd:370
      sameAs:https://doi.org/10.1007/s10549-008-9926-3
      keywords:
         African–American
         Breast cancer
         Race
         Survival
         Triple negative
         Tumor subtypes
         Oncology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-008-9926-3/MediaObjects/10549_2008_9926_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-008-9926-3/MediaObjects/10549_2008_9926_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-008-9926-3/MediaObjects/10549_2008_9926_Fig3_HTML.gif
      isPartOf:
         name:Breast Cancer Research and Treatment
         issn:
            1573-7217
            0167-6806
         volumeNumber:113
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Mary Jo Lund
            affiliation:
                  name:Emory University
                  address:
                     name:Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, USA
                     type:PostalAddress
                  type:Organization
                  name:Emory University School of Medicine
                  address:
                     name:Hematology and Oncology, Emory University School of Medicine, Atlanta, USA
                     type:PostalAddress
                  type:Organization
                  name:Emory University School of Medicine
                  address:
                     name:Winship Cancer Institute, Emory University School of Medicine, Atlanta, USA
                     type:PostalAddress
                  type:Organization
                  name:Emory University
                  address:
                     name:Georgia Cancer Center for Excellence at Grady, Emory University, Atlanta, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Katrina F. Trivers
            affiliation:
                  name:Centers for Disease Control and Prevention
                  address:
                     name:Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Peggy L. Porter
            affiliation:
                  name:Fred Hutchinson Cancer Research Center
                  address:
                     name:Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ralph J. Coates
            affiliation:
                  name:Centers for Disease Control and Prevention
                  address:
                     name:Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Brian Leyland-Jones
            affiliation:
                  name:Emory University School of Medicine
                  address:
                     name:Hematology and Oncology, Emory University School of Medicine, Atlanta, USA
                     type:PostalAddress
                  type:Organization
                  name:Emory University School of Medicine
                  address:
                     name:Winship Cancer Institute, Emory University School of Medicine, Atlanta, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Otis W. Brawley
            affiliation:
                  name:Emory University
                  address:
                     name:Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, USA
                     type:PostalAddress
                  type:Organization
                  name:Emory University School of Medicine
                  address:
                     name:Hematology and Oncology, Emory University School of Medicine, Atlanta, USA
                     type:PostalAddress
                  type:Organization
                  name:Emory University School of Medicine
                  address:
                     name:Winship Cancer Institute, Emory University School of Medicine, Atlanta, USA
                     type:PostalAddress
                  type:Organization
                  name:Emory University
                  address:
                     name:Georgia Cancer Center for Excellence at Grady, Emory University, Atlanta, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Elaine W. Flagg
            affiliation:
                  name:Centers for Disease Control and Prevention
                  address:
                     name:Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ruth M. O’Regan
            affiliation:
                  name:Emory University School of Medicine
                  address:
                     name:Hematology and Oncology, Emory University School of Medicine, Atlanta, USA
                     type:PostalAddress
                  type:Organization
                  name:Emory University School of Medicine
                  address:
                     name:Winship Cancer Institute, Emory University School of Medicine, Atlanta, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Sheryl G. A. Gabram
            affiliation:
                  name:Emory University School of Medicine
                  address:
                     name:Winship Cancer Institute, Emory University School of Medicine, Atlanta, USA
                     type:PostalAddress
                  type:Organization
                  name:Emory University
                  address:
                     name:Georgia Cancer Center for Excellence at Grady, Emory University, Atlanta, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:J. William Eley
            affiliation:
                  name:Emory University School of Medicine
                  address:
                     name:Hematology and Oncology, Emory University School of Medicine, Atlanta, USA
                     type:PostalAddress
                  type:Organization
                  name:Emory University School of Medicine
                  address:
                     name:Winship Cancer Institute, Emory University School of Medicine, Atlanta, USA
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Breast Cancer Research and Treatment
      issn:
         1573-7217
         0167-6806
      volumeNumber:113
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Emory University
      address:
         name:Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, USA
         type:PostalAddress
      name:Emory University School of Medicine
      address:
         name:Hematology and Oncology, Emory University School of Medicine, Atlanta, USA
         type:PostalAddress
      name:Emory University School of Medicine
      address:
         name:Winship Cancer Institute, Emory University School of Medicine, Atlanta, USA
         type:PostalAddress
      name:Emory University
      address:
         name:Georgia Cancer Center for Excellence at Grady, Emory University, Atlanta, USA
         type:PostalAddress
      name:Centers for Disease Control and Prevention
      address:
         name:Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, USA
         type:PostalAddress
      name:Fred Hutchinson Cancer Research Center
      address:
         name:Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, USA
         type:PostalAddress
      name:Centers for Disease Control and Prevention
      address:
         name:Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, USA
         type:PostalAddress
      name:Emory University School of Medicine
      address:
         name:Hematology and Oncology, Emory University School of Medicine, Atlanta, USA
         type:PostalAddress
      name:Emory University School of Medicine
      address:
         name:Winship Cancer Institute, Emory University School of Medicine, Atlanta, USA
         type:PostalAddress
      name:Emory University
      address:
         name:Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, USA
         type:PostalAddress
      name:Emory University School of Medicine
      address:
         name:Hematology and Oncology, Emory University School of Medicine, Atlanta, USA
         type:PostalAddress
      name:Emory University School of Medicine
      address:
         name:Winship Cancer Institute, Emory University School of Medicine, Atlanta, USA
         type:PostalAddress
      name:Emory University
      address:
         name:Georgia Cancer Center for Excellence at Grady, Emory University, Atlanta, USA
         type:PostalAddress
      name:Centers for Disease Control and Prevention
      address:
         name:Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, USA
         type:PostalAddress
      name:Emory University School of Medicine
      address:
         name:Hematology and Oncology, Emory University School of Medicine, Atlanta, USA
         type:PostalAddress
      name:Emory University School of Medicine
      address:
         name:Winship Cancer Institute, Emory University School of Medicine, Atlanta, USA
         type:PostalAddress
      name:Emory University School of Medicine
      address:
         name:Winship Cancer Institute, Emory University School of Medicine, Atlanta, USA
         type:PostalAddress
      name:Emory University
      address:
         name:Georgia Cancer Center for Excellence at Grady, Emory University, Atlanta, USA
         type:PostalAddress
      name:Emory University School of Medicine
      address:
         name:Hematology and Oncology, Emory University School of Medicine, Atlanta, USA
         type:PostalAddress
      name:Emory University School of Medicine
      address:
         name:Winship Cancer Institute, Emory University School of Medicine, Atlanta, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Mary Jo Lund
      affiliation:
            name:Emory University
            address:
               name:Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, USA
               type:PostalAddress
            type:Organization
            name:Emory University School of Medicine
            address:
               name:Hematology and Oncology, Emory University School of Medicine, Atlanta, USA
               type:PostalAddress
            type:Organization
            name:Emory University School of Medicine
            address:
               name:Winship Cancer Institute, Emory University School of Medicine, Atlanta, USA
               type:PostalAddress
            type:Organization
            name:Emory University
            address:
               name:Georgia Cancer Center for Excellence at Grady, Emory University, Atlanta, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Katrina F. Trivers
      affiliation:
            name:Centers for Disease Control and Prevention
            address:
               name:Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, USA
               type:PostalAddress
            type:Organization
      name:Peggy L. Porter
      affiliation:
            name:Fred Hutchinson Cancer Research Center
            address:
               name:Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, USA
               type:PostalAddress
            type:Organization
      name:Ralph J. Coates
      affiliation:
            name:Centers for Disease Control and Prevention
            address:
               name:Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, USA
               type:PostalAddress
            type:Organization
      name:Brian Leyland-Jones
      affiliation:
            name:Emory University School of Medicine
            address:
               name:Hematology and Oncology, Emory University School of Medicine, Atlanta, USA
               type:PostalAddress
            type:Organization
            name:Emory University School of Medicine
            address:
               name:Winship Cancer Institute, Emory University School of Medicine, Atlanta, USA
               type:PostalAddress
            type:Organization
      name:Otis W. Brawley
      affiliation:
            name:Emory University
            address:
               name:Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, USA
               type:PostalAddress
            type:Organization
            name:Emory University School of Medicine
            address:
               name:Hematology and Oncology, Emory University School of Medicine, Atlanta, USA
               type:PostalAddress
            type:Organization
            name:Emory University School of Medicine
            address:
               name:Winship Cancer Institute, Emory University School of Medicine, Atlanta, USA
               type:PostalAddress
            type:Organization
            name:Emory University
            address:
               name:Georgia Cancer Center for Excellence at Grady, Emory University, Atlanta, USA
               type:PostalAddress
            type:Organization
      name:Elaine W. Flagg
      affiliation:
            name:Centers for Disease Control and Prevention
            address:
               name:Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, USA
               type:PostalAddress
            type:Organization
      name:Ruth M. O’Regan
      affiliation:
            name:Emory University School of Medicine
            address:
               name:Hematology and Oncology, Emory University School of Medicine, Atlanta, USA
               type:PostalAddress
            type:Organization
            name:Emory University School of Medicine
            address:
               name:Winship Cancer Institute, Emory University School of Medicine, Atlanta, USA
               type:PostalAddress
            type:Organization
      name:Sheryl G. A. Gabram
      affiliation:
            name:Emory University School of Medicine
            address:
               name:Winship Cancer Institute, Emory University School of Medicine, Atlanta, USA
               type:PostalAddress
            type:Organization
            name:Emory University
            address:
               name:Georgia Cancer Center for Excellence at Grady, Emory University, Atlanta, USA
               type:PostalAddress
            type:Organization
      name:J. William Eley
      affiliation:
            name:Emory University School of Medicine
            address:
               name:Hematology and Oncology, Emory University School of Medicine, Atlanta, USA
               type:PostalAddress
            type:Organization
            name:Emory University School of Medicine
            address:
               name:Winship Cancer Institute, Emory University School of Medicine, Atlanta, USA
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, USA
      name:Hematology and Oncology, Emory University School of Medicine, Atlanta, USA
      name:Winship Cancer Institute, Emory University School of Medicine, Atlanta, USA
      name:Georgia Cancer Center for Excellence at Grady, Emory University, Atlanta, USA
      name:Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, USA
      name:Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, USA
      name:Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, USA
      name:Hematology and Oncology, Emory University School of Medicine, Atlanta, USA
      name:Winship Cancer Institute, Emory University School of Medicine, Atlanta, USA
      name:Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, USA
      name:Hematology and Oncology, Emory University School of Medicine, Atlanta, USA
      name:Winship Cancer Institute, Emory University School of Medicine, Atlanta, USA
      name:Georgia Cancer Center for Excellence at Grady, Emory University, Atlanta, USA
      name:Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, USA
      name:Hematology and Oncology, Emory University School of Medicine, Atlanta, USA
      name:Winship Cancer Institute, Emory University School of Medicine, Atlanta, USA
      name:Winship Cancer Institute, Emory University School of Medicine, Atlanta, USA
      name:Georgia Cancer Center for Excellence at Grady, Emory University, Atlanta, USA
      name:Hematology and Oncology, Emory University School of Medicine, Atlanta, USA
      name:Winship Cancer Institute, Emory University School of Medicine, Atlanta, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {šŸ”—}(213)

Analytics and Tracking {šŸ“Š}

  • Google Tag Manager

Libraries {šŸ“š}

  • Clipboard.js
  • Prism.js

CDN Services {šŸ“¦}

  • Crossref

4.8s.